These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32815676)

  • 1. Prenatally Diagnosed Fetal Aneuploidy: Natural History and Subsequent Management.
    Murphy NC; Dunne H; Flood K
    Ir Med J; 2020 Mar; 113(3):34. PubMed ID: 32815676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
    La Verde M; De Falco L; Torella A; Savarese G; Savarese P; Ruggiero R; Conte A; Fico V; Torella M; Fico A
    BMC Med Genomics; 2021 Mar; 14(1):93. PubMed ID: 33785045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prenatal diagnosis and outcome of pregnancy for women with high risks by screening of fetal free DNA from peripheral blood samples].
    Li Z; Duan H; Liu W; Zhu R; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan; 41(1):1-7. PubMed ID: 38171551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective analysis of 44 578 pregnancies undergoing non-invasive prenatal testing in Weifang].
    Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1065-1068. PubMed ID: 32924102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of pregnancies with a diagnosis of trisomy 18 or trisomy 13; a retrospective case series.
    Houlihan OA; O'Donoghue K
    BMC Pregnancy Childbirth; 2013 Nov; 13():209. PubMed ID: 24237681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal reflex DNA screening for trisomy 21, 18 and 13.
    Wald NJ
    Expert Rev Mol Diagn; 2018 May; 18(5):399-401. PubMed ID: 29633889
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.
    Rose NC; Barrie ES; Malinowski J; Jenkins GP; McClain MR; LaGrave D; Leung ML;
    Genet Med; 2022 Jul; 24(7):1379-1391. PubMed ID: 35608568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of non-invasive prenatal testing in preventing birth defects].
    Zhang W; Li S; Tang P; Wang J; Gu S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1061-1064. PubMed ID: 32924101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive prenatal testing for aneuploidy screening.
    Spencer R; Hewitt H; McCarthy L; Wimalasundera R; Pandya P
    BMJ; 2020 Oct; 371():m3930. PubMed ID: 33109517
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
    Mesoraca A; Margiotti K; Dello Russo C; Cesta A; Cima A; Longo SA; Barone MA; Viola A; Sparacino D; Giorlandino C
    Genet Res (Camb); 2020 Jun; 102():e5. PubMed ID: 32539871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
    Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of national prenatal screening on the time of diagnosis and outcome of pregnancies affected with common trisomies, a cohort study in the Northern Netherlands.
    Bouman K; Bakker MK; Birnie E; Ter Beek L; Bilardo CM; van Langen IM; de Walle HE
    BMC Pregnancy Childbirth; 2017 Jan; 17(1):4. PubMed ID: 28056858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis.
    Torres Aguilar MR; Carrasco Salas P; Santos Rosa C; Bueno Rodríguez G; Martínez-Bonet E; Carreto Alba P; León-Justel A; Granell Escobar MR
    Taiwan J Obstet Gynecol; 2021 Jul; 60(4):745-751. PubMed ID: 34247818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective clinical evaluation of Momguard non-invasive prenatal test in 1011 Korean high-risk pregnant women.
    Hu HJ; Lee MY; Cho DY; Oh M; Kwon YJ; Han YJ; Ryu HM; Kim YN; Won HS
    J Obstet Gynaecol; 2020 Nov; 40(8):1090-1095. PubMed ID: 31826681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
    Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.